Further to DrugAlert vol 662, HPS Pharmacies wish to advise that Gilead, in consultation with the Therapeutic Goods Administration (TGA), has given notice of changes to the packaging of AmBisome® as follows:
Liposomal amphotericin 50mg
AmBisome® will now be dispatched in an additional cardboard outer carton that will include:
- 1x AmBisome® Filter Replacement Guide;
- 1x bag of replacement 5μm sterile filters; and
- 10x cartons of AmBisome® (liposomal amphotericin) 50mg powder for injection.
Please follow the instructions provided in the ‘AmBisome® Filter Replacement Guide’ to replace the filters impacted by the previous Product Defect Correction. Gilead advises that supply of AmBisome® will likely continue in this format for 9-12 months. Following this period, it is anticipated that supply will return to normal.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Gilead on (03) 9272 4432, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates